重大事项：
上海医药(02607)：常州制药厂的阿普米司特片获得批准生产
绿叶制药(02186)：赞必佳®(注射用芦比替定)在中国大陆获批上市
山东新华制药股份(00719)：阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价
和黄医药(00013)与信达生物(01801)联合宣布爱优特®联合达伯舒®获中国国家药监局附条件批准用于治疗晚期子宫内膜癌
紫金矿业(02899)：秘鲁 La Arena 金矿和二期项目完成交割
方舟健客(06086)纳入恒生香港上市生物科技指数成份股
第一太平(00142)拟分拆Maynilad的股份于菲律宾证券交易所独立上市
广汽集团(02238)及全资子公司广汽资本拟将巨湾技研18.82%股权转让给广汽工业集团
经营业绩：
越秀地产(00123)前11个月累计合同销售额约1010.2亿元，同比下降约24%
雅居乐集团(03383)前11个月预售金额合计147.5亿元 同比减少64.81%
正荣地产(06158)前11个月累计合约销售金额约59.9亿元，同比下降58.6%
如需了解更多详情，请参阅智通财经网(www.zhitongcaijing.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.